CLEAR Outcomes Trial: A Brief Summary

"Although statins play a pivotal role in the prevention of atherosclerotic cardiovascular disease, many patients fail to achieve recommended lipid levels due to statin-associated muscle symptoms." The CLEAR Outcomes trial evaluated the effect of bempedoic acid on cardiovascular events in patients with statin intolerance. Steve Nissen, MD, Chief Academic Officer of Cleveland Clinic’s Heart, Vascular and Thoracic Institute, provides a summary of this trial.